Compile Data Set for Download or QSAR
maximum 50k data
Found 146 with Last Name = 'barroga' and Initial = 'cf'
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396286(US10314832, Compound 2)
Affinity DataIC50:  13nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396284(US10314832, Compound 1)
Affinity DataIC50:  28.5nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396287(US10314832, Compound 3)
Affinity DataIC50:  38.5nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396292(US10314832, Compound 8)
Affinity DataIC50:  83nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396291(US10314832, Compound 7)
Affinity DataIC50:  183nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396288(US10314832, Compound 11 | US10314832, Compound 4)
Affinity DataIC50:  805nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396289(US10314832, Compound 5)
Affinity DataIC50:  1.27E+3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396298(US10314832, Compound 15)
Affinity DataIC50:  1.39E+3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396290(US10314832, Compound 6)
Affinity DataIC50:  2.10E+3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396299(US10314832, Compound 16)
Affinity DataIC50:  2.57E+3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396302(US10314832, Compound 19)
Affinity DataIC50:  3.90E+3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396301(US10314832, Compound 18)
Affinity DataIC50:  6.00E+3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396297(US10314832, Compound 14)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396288(US10314832, Compound 11 | US10314832, Compound 4)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396294(US10314832, Compound 10)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396300(US10314832, Compound 17)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396293(US10314832, Compound 9)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396296(US10314832, Compound 12)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM417391(US10457672, Compound 1)
Affinity DataEC50:  5nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM417424(US10457672, Compound 2)
Affinity DataEC50:  2nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM417465(US10457672, Compound 3)
Affinity DataEC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM417467(US10457672, Compound 4)
Affinity DataEC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM417489(US10457672, Compound 9)
Affinity DataEC50:  100nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM417490(US10457672, Compound 10)
Affinity DataEC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM417514(US10457672, Compound 11)
Affinity DataEC50:  13nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM417518(US10457672, Compound 12)
Affinity DataEC50:  5nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM417527(US10457672, Compound 13)
Affinity DataEC50:  192nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM417775(US10457672, Compound 14)
Affinity DataEC50:  306nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM417776(US10457672, Compound 15)
Affinity DataEC50:  90nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM417830(US10457672, Compound 16)
Affinity DataEC50:  7nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM417904(US10457672, Compound 18)
Affinity DataEC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM417998(US10457672, Compound 19)
Affinity DataEC50:  3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM418005(US10457672, Compound 21)
Affinity DataEC50:  31nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM418061(US10457672, Compound 28)
Affinity DataEC50:  9nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM418321(US10457672, Compound 61)
Affinity DataEC50:  25nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM418322(US10457672, Compound 68)
Affinity DataEC50:  6nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM418323(US10457672, Compound 69)
Affinity DataEC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM418324(US10457672, Compound 71)
Affinity DataEC50:  2.5nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM418325(US10457672, Compound 76)
Affinity DataEC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM418326(US10457672, Compound 80)
Affinity DataEC50:  10nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM418327(US10457672, Compound 207)
Affinity DataEC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM418328(US10457672, Compound 208)
Affinity DataEC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM418329(US10457672, Compound 209)
Affinity DataEC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM418330(US10457672, Compound 210)
Affinity DataEC50:  2nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM418331(US10457672, Compound 213)
Affinity DataEC50:  18nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM418332(US10457672, Compound 214)
Affinity DataEC50:  10nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM418333(US10457672, Compound 216)
Affinity DataEC50:  11nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM418334(US10457672, Compound 217)
Affinity DataEC50:  343nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM418335(US10457672, Compound 222)
Affinity DataEC50:  3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1/Protein Wnt-3a(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM418336(US10457672, Compound 232)
Affinity DataEC50:  134nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 146 total ) | Next | Last >>
Jump to: